Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PALYNZIQ safely and effectively. See full prescribing information for PALYNZIQ. PALYNZIQ (pegvaliase-pqpz) injection, for subcutaneous use Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
Palynziq is indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management.
- generic_name
- pegvaliase-pqpz
- product_names
- pegvaliase-pqpz
- ndc
- 68135-058, 68135-058-89, 68135-058-90, 68135-756, 68135-756-19, 68135-756-20, 68135-673, 68135-673-39, 68135-673-40, 68135-673-45
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en